KMID : 1011920210220010009
|
|
International Journal of Arrhythmia 2021 Volume.22 No. 1 p.9 ~ p.9
|
|
Factors predicting poor anticoagulant control on warfarin in a Thai population with non-valvular atrial fibrillation (NVAF): the ACAChE score
|
|
Lertsanguansinchai Piyoros
Huntrakul Anurut Rungpradubvong Voravut Chokesuwattanaskul Ronpichai Prechawat Somchai
|
|
Abstract
|
|
|
Background: In many low- to middle-income countries in Asia, patients with NVAF usually received warfarin for thromboembolic prevention due to cost-effectiveness. The SAMe-TT2R2 score has been proposed to predict TTR in NVAF patients. However, the SAMe-TT2R2 score has not been much validated in Asian population. Interestingly, it may overestimate patients who had TTR?65% due to regarding being Asians as a risk factor.
Objectives: To determine the factors predicting poor anticoagulant control on warfarin, create new scoring system, and compare with the SAMe-TT2R2 score in a Thai population with NVAF.
Methods: This is a retrospective study in a tertiary care hospital. We enrolled NVAF patients who received warfarin from January 2014 to December 2018. TTR was calculated based on Rosendaal method. Multiple logistic regression and AUC-ROC curve were used for analysis.
Results: A total of 864 patients were enrolled with mean age of 73.6?¡¾?11.58 years. The mean TTR was 48.1?¡¾?25.2%. Using multivariate regression analysis, the predictive factors for TTR?65% were antiplatelet use (OR 4.49, p?¡Â?0.001), LVEF?40% (OR 1.92, p?=?0.037), chronic kidney disease (GFR?50 ml/min/1.73 m2) (OR 1.68, p?=?0.013), history of CHF (OR 1.7, p?=?0.047), and age?¡Ã?75 years (OR 1.4, p?=?0.037). Based on the regression coefficients, we developed the new scoring system called ACAChE score [A, antiplatelet use (4 points); C, chronic kidney disease, GFR?50 ml/min/1.73 m2 (2 points); A, age?¡Ã?75 years (1 point); Ch, history of CHF (2 points); E, LVEF?40% (2 points)]. ROC curve showed discrimination performance of the ACAChE score and SAMe-TT2R2 score for prediction of TTR?65% with the C-statistic of 0.62 (95%CI 0.57?0.65) and 0.54 (95%CI 0.50?0.58), respectively.
Conclusion: In Thai NVAF patients, the ACAChE score (antiplatelet use, chronic kidney disease (GFR?50 ml/min/1.73 m2), age?¡Ã?75 years, history of congestive heart failure, and LVEF?40%) has better prediction for TTR?65% than SAMe-TT2R2 score. Thus, it expected to guide the selection of oral anticoagulation in Asian patients with NVAF.
|
|
KEYWORD
|
|
Atrial fibrillation, Warfarin, Time in therapeutic range, Same-TT2R2, TTR
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|